JPH0940632A - Diacylglycerol derivative - Google Patents
Diacylglycerol derivativeInfo
- Publication number
- JPH0940632A JPH0940632A JP19538695A JP19538695A JPH0940632A JP H0940632 A JPH0940632 A JP H0940632A JP 19538695 A JP19538695 A JP 19538695A JP 19538695 A JP19538695 A JP 19538695A JP H0940632 A JPH0940632 A JP H0940632A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- diacylglycerol
- group
- lactone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YIBHDAKUJGXPLH-UNHHQYQHSA-N [(2s)-2-(adamantane-1-carbonyloxy)-3-hydroxypropyl] adamantane-1-carboxylate Chemical compound C1C(C2)CC(C3)CC2CC13C(=O)O[C@@H](CO)COC(=O)C1(C2)CC(C3)CC2CC3C1 YIBHDAKUJGXPLH-UNHHQYQHSA-N 0.000 title claims abstract description 22
- 125000002252 acyl group Chemical group 0.000 claims abstract description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 7
- 229930195729 fatty acid Natural products 0.000 claims abstract description 7
- 239000000194 fatty acid Substances 0.000 claims abstract description 7
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000002502 liposome Substances 0.000 abstract description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 6
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003905 agrochemical Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- NEZDNQCXEZDCBI-UHFFFAOYSA-N 2-azaniumylethyl 2,3-di(tetradecanoyloxy)propyl phosphate Chemical group CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCC NEZDNQCXEZDCBI-UHFFFAOYSA-N 0.000 abstract description 3
- SXZYCXMUPBBULW-LECHCGJUSA-N D-(-)-Gulono-gamma-lactone Chemical compound OC[C@@H](O)[C@@H]1OC(=O)[C@H](O)[C@@H]1O SXZYCXMUPBBULW-LECHCGJUSA-N 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 239000002960 lipid emulsion Substances 0.000 abstract description 2
- UNYNVICDCJHOPO-UHFFFAOYSA-N quabalactone III Natural products CC1OC(=O)C(O)=C1C UNYNVICDCJHOPO-UHFFFAOYSA-N 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 150000002772 monosaccharides Chemical class 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 150000001982 diacylglycerols Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- SLKDGVPOSSLUAI-PGUFJCEWSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC SLKDGVPOSSLUAI-PGUFJCEWSA-N 0.000 description 3
- JEJLGIQLPYYGEE-UHFFFAOYSA-N 1,2-dipalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC JEJLGIQLPYYGEE-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- -1 Ammonium ions Chemical class 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-KKQCNMDGSA-N D-gulonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-KKQCNMDGSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000007514 bases Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- IOQLZVQKTDKIOZ-UHFFFAOYSA-N 2,3,4,5,6,7-hexahydroxyheptanoic acid;sodium;hydrate Chemical compound O.[Na].OCC(O)C(O)C(O)C(O)C(O)C(O)=O IOQLZVQKTDKIOZ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-MBMOQRBOSA-N D-mannonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-MBMOQRBOSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 229950006191 gluconic acid Drugs 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229960003681 gluconolactone Drugs 0.000 description 2
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- NUYDBDGECBIUPJ-FJPOHGBRSA-N (3r,4s,5r)-3,4-dihydroxy-5-[(1s,2r,3r)-1,2,3,4-tetrahydroxybutyl]oxolan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H]1OC(=O)[C@H](O)[C@@H]1O NUYDBDGECBIUPJ-FJPOHGBRSA-N 0.000 description 1
- SXZYCXMUPBBULW-ZRMNMSDTSA-N (3s,4r)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one Chemical compound OC[C@@H](O)C1OC(=O)[C@@H](O)[C@H]1O SXZYCXMUPBBULW-ZRMNMSDTSA-N 0.000 description 1
- PKQZVASULXKBJV-UHFFFAOYSA-N (4-hydroxyphenyl)-dimethylsulfanium;methyl sulfate Chemical compound COS([O-])(=O)=O.C[S+](C)C1=CC=C(O)C=C1 PKQZVASULXKBJV-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JFBCSFJKETUREV-UHFFFAOYSA-N 1,2 ditetradecanoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCC JFBCSFJKETUREV-UHFFFAOYSA-N 0.000 description 1
- LVNGJLRDBYCPGB-UHFFFAOYSA-N 1,2-distearoylphosphatidylethanolamine Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- ADHNUPOJJCKWRT-UHFFFAOYSA-N 2,4-octadecadienoic acid Natural products CCCCCCCCCCCCCC=CC=CC(O)=O ADHNUPOJJCKWRT-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- XNPOFXIBHOVFFH-UHFFFAOYSA-N N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide Chemical compound C1CCCCC1N=C=NCCN1CCOCC1 XNPOFXIBHOVFFH-UHFFFAOYSA-N 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- PFYXSUNOLOJMDX-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)ON1C(=O)CCC1=O PFYXSUNOLOJMDX-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000002691 unilamellar liposome Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、多価水酸基を有す
るジアシルグリセロール誘導体に関する。本発明のジア
シルグリセロール誘導体は、リポソームまたは脂肪乳剤
等の小胞体形成剤として、また医薬、農薬、化粧品の原
料などとして利用される。TECHNICAL FIELD The present invention relates to a diacylglycerol derivative having a polyvalent hydroxyl group. The diacylglycerol derivative of the present invention is used as an endoplasmic reticulum forming agent such as a liposome or a fat emulsion, and as a raw material for medicines, agricultural chemicals, cosmetics and the like.
【0002】[0002]
【従来の技術】リポソームはリン脂質の二分子膜ベシク
ルであり、多分野での応用が試みられている。特に、医
薬運搬体、診断・検出用の担体などへの応用が注目され
ており、リポソームの安定性の改善、および血中濃度の
維持が大きな課題となっている。ところで、ジアシルグ
リセロール誘導体はリポソームの膜形成成分などとして
広く利用されているが、後述の一般式(1)で表わされ
るような多価水酸基を有するジアシルグリセロール誘導
体は知られていない。2. Description of the Related Art Liposomes are phospholipid bilayer vesicles, and their applications have been tried in various fields. In particular, attention is focused on its application to drug carriers, diagnostic / detection carriers, and the like, and improvement of liposome stability and maintenance of blood concentration have become major issues. By the way, diacylglycerol derivatives are widely used as a membrane-forming component of liposomes, but diacylglycerol derivatives having a polyvalent hydroxyl group represented by the general formula (1) described later are not known.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、多価
水酸基を有する新規かつ有用なジアシルグリセロール誘
導体を提供することである。An object of the present invention is to provide a new and useful diacylglycerol derivative having a polyvalent hydroxyl group.
【0004】[0004]
【課題を解決するための手段】本発明は、下記一般式
(1)で表わされるジアシルグリセロール誘導体であ
る。DISCLOSURE OF THE INVENTION The present invention is a diacylglycerol derivative represented by the following general formula (1).
【化2】 (式(2)において、Mは1価のカウンターイオン、式
(3)において、R3は水素原子またはメチル基を表わ
す。)を表わす。R1C(=O)およびR2C(=O)は炭素
数3〜30の脂肪酸のアシル残基を表わし、同一でも異
なっていてもよい。nは2〜6の正数を表わす。)Embedded image (In the formula (2), M represents a monovalent counter ion, and in the formula (3), R 3 represents a hydrogen atom or a methyl group). R 1 C (═O) and R 2 C (═O) represent an acyl residue of a fatty acid having 3 to 30 carbon atoms and may be the same or different. n represents a positive number of 2 to 6. )
【0005】一般式(1)においてR1C(=O)または
R2C(=O)で表わされる脂肪酸のアシル残基は、炭素
数3〜30、好ましくは8〜20のアシル残基である。
このようなアシル残基の具体的なものとしては、プロピ
オン酸、酪酸、カプロン酸、カプリル酸、ペラルゴン
酸、カプリン酸、ウンデカン酸、ラウリル酸、ミリスチ
ン酸、パルミチン酸、ステアリン酸、アラキン酸、ベヘ
ン酸、リグノセリン酸、ソロチン酸、モンタン酸、メリ
シン酸、2−エチルヘキサン酸等の飽和脂肪酸のアシル
残基;オレイン酸、リノール酸、リノレン酸、エルカ
酸、2,4−オクタデカジエン酸等の不飽和脂肪酸のア
シル残基;イソステアリン酸等の分岐脂肪酸のアシル残
基;リシノール酸、1,2−ヒドロキシステアリン酸等
のアルキル基中に水酸基を有する脂肪酸のアシル残基な
どがあげられる。R1C(=O)とR2C(=O)とは同一で
あってもよいし、異なっていてもよい。The acyl residue of the fatty acid represented by R 1 C (═O) or R 2 C (═O) in the general formula (1) is an acyl residue having 3 to 30 carbon atoms, preferably 8 to 20 carbon atoms. is there.
Specific examples of such acyl residues include propionic acid, butyric acid, caproic acid, caprylic acid, pelargonic acid, capric acid, undecanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid. Acyl residues of saturated fatty acids such as acids, lignoceric acid, solotic acid, montanic acid, melissic acid, 2-ethylhexanoic acid; oleic acid, linoleic acid, linolenic acid, erucic acid, 2,4-octadecadienoic acid, etc. An acyl residue of an unsaturated fatty acid; an acyl residue of a branched fatty acid such as isostearic acid; an acyl residue of a fatty acid having a hydroxyl group in the alkyl group such as ricinoleic acid and 1,2-hydroxystearic acid. R 1 C (═O) and R 2 C (═O) may be the same or different.
【0006】本発明のジアシルグリセロール誘導体をリ
ポソームの膜形成成分として利用する場合には、R1C
(=O)またはR2C(=O)で表わされる脂肪酸のアシル
残基は、安定なリポソームが形成できるという理由か
ら、ミリスチン酸、パルミチン酸、ステアリン酸、オレ
イン酸、2,4−オクタデカジエン酸などのアシル残基
が好ましく、特にパルミチン酸、ステアリン酸、オレイ
ン酸のアシル残基が好ましい。When the diacylglycerol derivative of the present invention is used as a membrane-forming component of liposome, R 1 C
The acyl residue of the fatty acid represented by (= O) or R 2 C (= O) is capable of forming stable liposomes, and therefore myristic acid, palmitic acid, stearic acid, oleic acid, 2,4-octadeca An acyl residue such as dienoic acid is preferable, and an acyl residue such as palmitic acid, stearic acid and oleic acid is particularly preferable.
【0007】一般式(2)においてMは1価のカウンタ
ーイオンであり、PO4 -の対イオンとなる1価の陽イオ
ンであれば制限されない。具体的なものとしては、
H+;Na+、K+等のアルカリ金属イオン;NH4 +、(C
H3)4N+、(C2H5)4N+、(C3H7)4N+、(CH3)3N+
H、(C2H5)3N+H、(C3H7)3N+H、(HOCH2CH
2)3N+H、C5H6N+H(ピリジニウムイオン)等のア
ンモニウムイオンなどがあげられる。In the general formula (2), M is a monovalent counter ion and is not limited as long as it is a monovalent cation which is a counter ion of PO 4 − . Specifically,
H + ; alkali metal ions such as Na + and K + ; NH 4 + , (C
H 3) 4 N +, ( C 2 H 5) 4 N +, (C 3 H 7) 4 N +, (CH 3) 3 N +
H, (C 2 H 5) 3 N + H, (C 3 H 7) 3 N + H, (HOCH 2 CH
2 ) Ammonium ions such as 3 N + H and C 5 H 6 N + H (pyridinium ions).
【0008】一般式(1)においてXが一般式(2)で
表わされるジアシルグリセロール誘導体は、例えば次の
ような製造方法により容易に製造することができる。す
なわち、ジミリストイルホスファチジルエタノールアミ
ン、ジパルミトイルホスファチジルエタノールアミン、
ジステアロイルホスファチジルエタノールアミンなどの
R1C(=O)およびR2C(=O)のアシル基を有するジア
シルホスファチジルエタノールアミン類と、D−グロン
酸−γ−ラクトン、グルコノラクトン、マンノン酸−γ
−ラクトン、D−リボン酸−γ−ラクトン、α,β−グ
ルコオクタン酸−γ−ラクトン、α−D−グルコヘプト
ン酸−γ−ラクトンなどの糖類のラクトン類とを反応さ
せることにより、本発明のジアシルグリセロール誘導体
を製造することができる。この場合、必要に応じてトリ
メチルアミン、トリエチルアミン、トリブチルアミン、
ピリジン等のアミン類やナトリウムメトキシド、ナトリ
ウムエトキシド、カリウムメトキシド、カリウムエトキ
シド等のアルコラートなどの塩基性化合物を用いること
ができる。The diacylglycerol derivative in which X in the general formula (1) is represented by the general formula (2) can be easily produced, for example, by the following production method. That is, dimyristoylphosphatidylethanolamine, dipalmitoylphosphatidylethanolamine,
Diacylphosphatidylethanolamines having R 1 C (═O) and R 2 C (═O) acyl groups such as distearoylphosphatidylethanolamine, and D-gulonic acid-γ-lactone, gluconolactone, mannonic acid- γ
-Lactone, D-ribbonic acid-γ-lactone, α, β-glucooctanoic acid-γ-lactone, α-D-glucoheptonic acid-γ-lactone, etc. Diacylglycerol derivatives can be prepared. In this case, if necessary, trimethylamine, triethylamine, tributylamine,
Basic compounds such as amines such as pyridine and alcoholates such as sodium methoxide, sodium ethoxide, potassium methoxide and potassium ethoxide can be used.
【0009】上記反応において、ジアシルホスファチジ
ルエタノールアミン類と糖類のラクトン類との反応仕込
み比は特に限定されないが、ジアシルホスファチジルエ
タノールアミン類:糖類のラクトン類のモル比で1:
0.5〜1:10、好ましくは1:0.9〜1:1.5
とするのが望ましい。また塩基性化合物の使用量はジア
シルホスファチジルエタノールアミン類に対して等モル
以上用いるのが好ましく、また塩基性化合物を反応溶媒
として用いてもよい。In the above reaction, the reaction charge ratio of the diacylphosphatidylethanolamines and the saccharide lactone is not particularly limited, but the molar ratio of the diacylphosphatidylethanolamines: sugar lactone is 1:
0.5 to 1:10, preferably 1: 0.9 to 1: 1.5
Is desirable. The amount of the basic compound used is preferably equimolar or more to the diacylphosphatidylethanolamines, and the basic compound may be used as a reaction solvent.
【0010】反応は、クロロホルム、酢酸エチル、ベン
ゼン、トルエン、アセトニトリル、テトラヒドロフラ
ン、1,4−ジオキサン、ジメチルホルムアミド、ジメ
チルアセトアミド、ジメチルスルホキシド、トリエチル
アミン、トリブチルアミン、トリ(2−ヒドロキシエチ
ル)アミン、ピリジンなどの有機溶媒およびこれらの混
合溶媒中で、反応温度−100〜+150℃、好ましく
は+30〜+100℃で、30分間〜200時間、好ま
しくは1〜24時間攪拌することにより行うことができ
る。反応終了後は、抽出、再結晶、再沈澱、吸着処理、
カラム処理、イオン交換樹脂処理、ゲル濾過、限外濾
過、透析、薄層クロマトグラフィーなどの方法により単
離・精製することができる。For the reaction, chloroform, ethyl acetate, benzene, toluene, acetonitrile, tetrahydrofuran, 1,4-dioxane, dimethylformamide, dimethylacetamide, dimethylsulfoxide, triethylamine, tributylamine, tri (2-hydroxyethyl) amine, pyridine, etc. In an organic solvent and a mixed solvent thereof at a reaction temperature of −100 to + 150 ° C., preferably +30 to + 100 ° C., for 30 minutes to 200 hours, preferably 1 to 24 hours. After completion of the reaction, extraction, recrystallization, reprecipitation, adsorption treatment,
It can be isolated and purified by methods such as column treatment, ion exchange resin treatment, gel filtration, ultrafiltration, dialysis, and thin layer chromatography.
【0011】上記製造方法において、糖類のラクトン類
としてD−グロン酸−γ−ラクトンを用いた場合の反応
を下記反応式(4)に示す。式中、R1C(=O)および
R2C(=O)は前記と同じものを示す。In the above production method, the reaction when D-gulonic acid-γ-lactone is used as the lactone of the saccharide is shown in the following reaction formula (4). In the formula, R 1 C (═O) and R 2 C (═O) have the same meanings as described above.
【化3】 Embedded image
【0012】また別な製造方法として、脱水縮合剤の存
在下に活性エステル化剤を用いて、D−グロン酸、D−
グルコン酸、マンノン酸、D−リボン酸、α,β−グル
コオクタン酸、α−D−グルコヘプトン酸などのアルド
ン酸類を活性化した後、ジミリストイルホスファチジル
エタノールアミン、ジパルミトイルホスファチジルエタ
ノールアミン、ジステアロイルホスファチジルエタノー
ルアミンなどのR1C(=O)およびR2C(=O)のアシル
基を有するジアシルホスファチジルエタノールアミン類
を反応させることにより、本発明のジアシルグリセロー
ル誘導体を製造することもできる。As another production method, an active esterifying agent is used in the presence of a dehydrating condensing agent to prepare D-gulonic acid and D-gulonic acid.
After activating aldonic acids such as gluconic acid, mannonic acid, D-ribbonic acid, α, β-glucooctanoic acid, α-D-glucoheptonic acid, dimyristoylphosphatidylethanolamine, dipalmitoylphosphatidylethanolamine, distearoylphosphatidyl The diacylglycerol derivative of the present invention can also be produced by reacting diacylphosphatidylethanolamines having an R 1 C (═O) and R 2 C (═O) acyl group such as ethanolamine.
【0013】上記脱水縮合剤としては、BOP試薬、
1,1′−カルボニルジイミダゾール、N−シクロヘキ
シル−N′−(2−モルホリノエチル)カルボジイミド
メソ−p−トルエンスルホネート、ジシクロヘキシル
カルボジイミド、ジエチルホスホロシアニデート、N−
エトキシカルボニル−2−エトキシ−1,2−ジヒドロ
キノリン、1−エチル−3−(3−ジメチルアミノプロ
ピル)カルボジイミド塩酸塩などがあげられる。As the dehydration condensation agent, a BOP reagent,
1,1′-carbonyldiimidazole, N-cyclohexyl-N ′-(2-morpholinoethyl) carbodiimide meso-p-toluenesulfonate, dicyclohexylcarbodiimide, diethylphosphorusanidate, N-
Examples thereof include ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride.
【0014】上記活性化エステル剤としては、N,N′
−ジスクシンイミジルカルボネート、1−ヒドロキシベ
ンゾトリアゾール、N−ヒドロキシフタルイミド、イソ
ブチルクロロホルメート、4−ヒドロキシフェニルジメ
チルスルホニウムメチルサルフェートなどがあげられ
る。反応は前記と同様の反応溶媒を用いて、同様の条件
により行うことができる。As the activated ester agent, N, N '
-Disuccinimidyl carbonate, 1-hydroxybenzotriazole, N-hydroxyphthalimide, isobutyl chloroformate, 4-hydroxyphenyl dimethyl sulfonium methyl sulfate, etc. are mentioned. The reaction can be carried out using the same reaction solvent as above under the same conditions.
【0015】さらに別な製造方法として、D−グロン
酸、D−グルコン酸、マンノン酸、D−リボン酸、α,
β−グルコオクタン酸、α−D−グルコヘプトン酸など
のアルドン酸類の酸クロリドと、前記ホスファチジルエ
タノールアミン類とを反応させることにより、本発明の
ジアシルグリセロール誘導体を製造することもできる。
反応は前記と同様の反応溶媒を用いて、同様の条件によ
り行うことができる。As another production method, D-gulonic acid, D-gluconic acid, mannonic acid, D-ribbonic acid, α,
The diacylglycerol derivative of the present invention can also be produced by reacting the acid chloride of an aldonic acid such as β-glucooctanoic acid or α-D-glucoheptonic acid with the phosphatidylethanolamine.
The reaction can be carried out using the same reaction solvent as above under the same conditions.
【0016】また一般式(1)においてXが一般式
(3)で表わされるジアシルグリセロール誘導体は、例
えば次のような製造方法により容易に製造することがで
きる。すなわち、1,2−ジミリストイルグリセロー
ル、1,2−ジパルミトイルグリセロール、1,2−ジ
ステアロイルグリセロールなどのR1C(=O)およびR2
C(=O)のアシル基を有する1,2−ジアシルグリセロ
ール類と、N,N′−カルボニルジイミダゾール(以
下、CDIという場合がある)とを反応させた後、グル
カミン、N−メチルグルカミンなどのアミノ基含有単糖
類を反応させることにより、本発明のジアシルグリセロ
ール誘導体を製造することができる。The diacylglycerol derivative in which X in the general formula (1) is represented by the general formula (3) can be easily produced, for example, by the following production method. That is, 1,2-dimyristoyl glycerol, 1,2-dipalmitoyl glycerol, 1,2-distearoyl glycerol and the like R 1 C (═O) and R 2
After reacting 1,2-diacylglycerols having a C (═O) acyl group with N, N′-carbonyldiimidazole (hereinafter sometimes referred to as CDI), glucamine and N-methylglucamine The diacylglycerol derivative of the present invention can be produced by reacting an amino group-containing monosaccharide such as
【0017】上記反応において、CDIの反応仕込み量
は1,2−ジアシルグリセロール類:CDIのモル比で
1:0.5〜1:10、好ましくは1:0.9〜1:
1.1、アミノ基含有単糖類の反応仕込み量は1,2−
ジアシルグルセロール類:アミノ基含有単糖類のモル比
で1:0.5〜1:10、好ましくは1:0.9〜1:
1.5とするのが望ましい。In the above reaction, the reaction charge of CDI is 1: 0.5 to 1:10, preferably 1: 0.9 to 1: 1, in the molar ratio of 1,2-diacylglycerols: CDI.
1.1, the amount of the amino group-containing monosaccharide charged in the reaction was
The molar ratio of diacyl glycerols: amino group-containing monosaccharides is 1: 0.5 to 1:10, preferably 1: 0.9 to 1 :.
A value of 1.5 is desirable.
【0018】反応は、クロロホルム、酢酸エチル、ベン
ゼン、トルエン、アセトニトリル、テトラヒドロフラ
ン、1,4−ジオキサン、ジメチルホルムアミド、ジメ
チルアセトアミド、ジメチルスルホキシドなどの有機溶
媒およびこれらの混合溶媒中で、反応温度−100〜+
150℃、好ましくは+30〜+100℃で、30分間
〜200時間、好ましくは1〜24時間攪拌することに
より行うことができる。反応終了後は、抽出、再結晶、
再沈澱、吸着処理、カラム処理、イオン交換樹脂処理、
ゲル濾過、限外濾過、透析、薄層クロマトグラフィーな
どの方法により単離・精製することができる。The reaction is carried out in an organic solvent such as chloroform, ethyl acetate, benzene, toluene, acetonitrile, tetrahydrofuran, 1,4-dioxane, dimethylformamide, dimethylacetamide, dimethylsulfoxide and the like and a mixed solvent thereof at a reaction temperature of -100 to 100.degree. +
It can be carried out by stirring at 150 ° C., preferably +30 to + 100 ° C., for 30 minutes to 200 hours, preferably 1 to 24 hours. After completion of the reaction, extraction, recrystallization,
Reprecipitation, adsorption treatment, column treatment, ion exchange resin treatment,
It can be isolated and purified by a method such as gel filtration, ultrafiltration, dialysis, and thin layer chromatography.
【0019】上記製造方法において、アミノ基含有単糖
類としてグルカミンを用いた場合の反応を下記反応式
(5)に示す。式中、R1C(=O)およびR2C(=O)は
前記と同じものを示す。In the above production method, the reaction when glucamine is used as the amino group-containing monosaccharide is shown in the following reaction formula (5). In the formula, R 1 C (═O) and R 2 C (═O) have the same meanings as described above.
【化4】 Embedded image
【0020】このようにして得られる本発明のジアシル
グリセロール誘導体は、リポソームの膜形成成分として
使用することができる。この場合、得られるリポソーム
表面に単糖類に由来する多価水酸基を導入することがで
き、これにより保存安定性を改善することができるとと
もに、長期間にわたって高い血中濃度を維持することが
できる。また本発明のジアシルグリセロール誘導体は、
脂肪乳剤、医薬、農薬、化粧品の原料などとして使用す
ることができる。The diacylglycerol derivative of the present invention thus obtained can be used as a membrane-forming component of liposomes. In this case, a polyvalent hydroxyl group derived from a monosaccharide can be introduced into the surface of the obtained liposome, whereby the storage stability can be improved and a high blood concentration can be maintained for a long period of time. Further, the diacylglycerol derivative of the present invention is
It can be used as a raw material for fat emulsions, medicines, agricultural chemicals, cosmetics and the like.
【0021】[0021]
【発明の効果】本発明のジアシルグリセロール誘導体は
新規かつ有用である。本発明のジアシルグリセロール誘
導体はリポソームの膜形成成分として使用することがで
き、この場合得られるリポソーム表面に単糖類に由来す
る多価水酸基を導入することができ、これにより保存安
定性を改善することができるとともに、長期間にわたっ
て高い血中濃度を維持することができる。また本発明の
ジアシルグリセロール誘導体は、脂肪乳剤、医薬、農
薬、化粧品の原料などとして使用することができる。The diacylglycerol derivative of the present invention is novel and useful. INDUSTRIAL APPLICABILITY The diacylglycerol derivative of the present invention can be used as a liposome membrane-forming component, and in this case, a polyvalent hydroxyl group derived from a monosaccharide can be introduced on the surface of the obtained liposome, thereby improving storage stability. In addition, it is possible to maintain a high blood concentration for a long period of time. Further, the diacylglycerol derivative of the present invention can be used as a raw material for fat emulsions, medicines, agricultural chemicals, cosmetics, and the like.
【0022】[0022]
【発明の実施の形態】以下、実施例により、さらに詳細
な説明を行うが、本発明はこれらに限定されない。 実施例1 クロロホルム10ml中に、ジパルミトイルホスファチ
ジルエタノールアミン0.5g(723μmol)、ト
リエチルアミン0.11g(1.08mmol)および
グルコノラクトン0.19g(1.08mmol)を溶
解し、60℃で10時間攪拌した。これを飽和食塩水で
洗浄し、有機層を無水硫酸ナトリウムで乾燥させた後、
減圧下に濃縮することにより、下式(6)で表わされる
白色粉末状の目的とするジアシルグリセロール誘導体を
得た。なお、得られた化合物は、展開溶媒にクロロホル
ム/メタノール(10:1(v/v))を用いた薄層ク
ロマトグラフィーにおいて1スポットであることを確認
した後、IRスペクトル、元素分析を行い同定した。分
析結果は下記の通りである。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto. Example 1 0.5 g (723 μmol) of dipalmitoylphosphatidylethanolamine, 0.11 g (1.08 mmol) of triethylamine and 0.19 g (1.08 mmol) of gluconolactone were dissolved in 10 ml of chloroform, and the mixture was dissolved at 60 ° C. for 10 hours. It was stirred. This was washed with saturated brine, the organic layer was dried over anhydrous sodium sulfate,
By concentrating under reduced pressure, the target diacylglycerol derivative represented by the following formula (6) in the form of white powder was obtained. The obtained compound was identified by performing IR spectrum and elemental analysis after confirming that it was one spot in thin layer chromatography using chloroform / methanol (10: 1 (v / v)) as a developing solvent. did. The analysis results are as follows.
【0023】[0023]
【化5】 Embedded image
【0024】IR(KBr法、cm-1) 3341(多価水酸基) 1737(カルボニル基(エステル結合)) 1648(カルボニル基(アミド結合)) 1070(P−O−C結合) 元素分析(C43H83NO14P) 計算値 C:59.4%,H:9.6%,N:1.6% 実測値 C:59.0%,H:10.3%,N:1.4%IR (KBr method, cm −1 ) 3341 (Polyvalent hydroxyl group) 1737 (Carbonyl group (ester bond)) 1648 (Carbonyl group (amide bond)) 1070 (P—O—C bond) Elemental analysis (C 43 H 83 NO 14 P) Calculated value C: 59.4%, H: 9.6%, N: 1.6% Actual value C: 59.0%, H: 10.3%, N: 1.4%
【0025】実施例2 クロロホルム5ml中に、1,2−ジパルミトイルグリ
セロール250mg(439μmol)およびN,N′
−カルボニルジイミダゾール0.071g(439μm
ol)を加え、室温で30分間攪拌した。さらにグルカ
ミン0.119g(658μmol)を加え、室温で2
4時間攪拌した。これを飽和食塩水で洗浄し、有機層を
無水硫酸ナトリウムで乾燥させた後、減圧下に濃縮する
ことにより、下式(7)で表わされる白色粉末状の目的
とするジアシルグリセロール誘導体を得た。なお、得ら
れた化合物は、展開溶媒にクロロホルム/メタノール
(10:1(v/v))を用いた薄層クロマトグラフィ
ーにおいて1スポットであることを確認した後、IRス
ペクトル、元素分析を行い同定した。分析結果は下記の
通りである。Example 2 250 mg (439 μmol) of 1,2-dipalmitoylglycerol and N, N ′ in 5 ml of chloroform.
-Carbonyldiimidazole 0.071 g (439 μm
ol) was added and the mixture was stirred at room temperature for 30 minutes. Add 0.119 g (658 μmol) of glucamine, and add 2 at room temperature.
Stir for 4 hours. This was washed with saturated saline, the organic layer was dried over anhydrous sodium sulfate, and then concentrated under reduced pressure to obtain the desired diacylglycerol derivative represented by the following formula (7) as a white powder. . The obtained compound was identified by performing IR spectrum and elemental analysis after confirming that it was one spot in thin layer chromatography using chloroform / methanol (10: 1 (v / v)) as a developing solvent. did. The analysis results are as follows.
【0026】[0026]
【化6】 [Chemical 6]
【0027】IR(KBr法、cm-1) 3300(多価水酸基) 1731(カルボニル基(エステル結合)) 1649(カルボニル基(アミド結合)) 元素分析(C42H81NO11) 計算値 C:65.0%,H:10.5%,N:1.8% 実測値 C:64.7%,H:11.0%,N:1.8%IR (KBr method, cm -1 ) 3300 (Polyvalent hydroxyl group) 1731 (Carbonyl group (ester bond)) 1649 (Carbonyl group (amide bond)) Elemental analysis (C 42 H 81 NO 11 ) Calculated value C: 65.0%, H: 10.5%, N: 1.8% Actual value C: 64.7%, H: 11.0%, N: 1.8%
【0028】実施例3 クロロホルム5ml中に、1,2−ジパルミトイルグリ
セロール250mg(439μmol)およびN,N′
−カルボニルジイミダゾール0.071g(439μm
ol)を加え、室温で30分間攪拌した。さらにN−メ
チルグルカミン0.128g(658μmol)を加
え、室温で24時間攪拌した。これを飽和食塩水で洗浄
し、有機層を無水硫酸ナトリウムで乾燥させた後、減圧
下に濃縮することにより、下式(8)で表わされる白色
粉末状の目的とするジアシルグリセロール誘導体を得
た。なお、得られた化合物は、展開溶媒にクロロホルム
/メタノール(10:1(v/v))を用いた薄層クロ
マトグラフィーにおいて1スポットであることを確認し
た後、IRスペクトル、元素分析を行い同定した。分析
結果は下記の通りである。Example 3 250 mg (439 μmol) of 1,2-dipalmitoylglycerol and N, N 'in 5 ml of chloroform.
-Carbonyldiimidazole 0.071 g (439 μm
ol) was added and the mixture was stirred at room temperature for 30 minutes. Furthermore, 0.128 g (658 μmol) of N-methylglucamine was added, and the mixture was stirred at room temperature for 24 hours. This was washed with saturated brine, the organic layer was dried over anhydrous sodium sulfate, and then concentrated under reduced pressure to obtain the desired diacylglycerol derivative represented by the following formula (8) as a white powder. . The obtained compound was identified by performing IR spectrum and elemental analysis after confirming that it was one spot in thin layer chromatography using chloroform / methanol (10: 1 (v / v)) as a developing solvent. did. The analysis results are as follows.
【0029】[0029]
【化7】 [Chemical 7]
【0030】IR(KBr法、cm-1) 3298(多価水酸基) 1735(カルボニル基(エステル結合)) 1624(カルボニル基(アミド結合)) 元素分析(C48H83NO11) 計算値 C:65.4%,H:10.6%,N:1.8% 実測値 C:65.2%,H:11.1%,N:1.7%IR (KBr method, cm -1 ) 3298 (Polyvalent hydroxyl group) 1735 (Carbonyl group (ester bond)) 1624 (Carbonyl group (amide bond)) Elemental analysis (C 48 H 83 NO 11 ) Calculated value C: 65.4%, H: 10.6%, N: 1.8% Actual value C: 65.2%, H: 11.1%, N: 1.7%
【0031】参考例 卵黄ホスファチジルコリン20mg(26μmol)、
コレステロール3.9mg(10μmol)および実施
例1で得られたジアシルグリセロール誘導体2.4mg
(前記二者の合計量に対して10重量%)をナス型フラ
スコに入れ、2mlのベンゼンに溶解させた後、凍結乾
燥した。これに生理的食塩水1mlを加え、バス型超音
波照射およびボルテックスミキサーにより、多重層リポ
ソームを得た。さらにエクスツルーダーにより3.0、
1.0、0.2μmのポリカーボネートメンブランを順
次通過させて大きな一枚膜のリポソームを得た。得られ
たリポソームの粒径をレーザー散乱粒度分布計(NIC
OMP社製、NICOMP370HPL、商標)を用い
て測定したところ、粒径180nm(CV値14%)で
あった。上記リポソームを5℃で3週間静置したのち、
再び粒径を測定したところ192nm(CV値18%)
であり、安定性に優れていた。Reference Example Egg yolk phosphatidylcholine 20 mg (26 μmol),
Cholesterol 3.9 mg (10 μmol) and diacylglycerol derivative 2.4 mg obtained in Example 1
(10% by weight based on the total amount of the above two) was placed in an eggplant-shaped flask, dissolved in 2 ml of benzene, and then freeze-dried. To this, 1 ml of physiological saline was added, and a multi-layer liposome was obtained by bath-type ultrasonic irradiation and a vortex mixer. 3.0 by Extruder,
A large unilamellar liposome was obtained by sequentially passing through a polycarbonate membrane of 1.0 and 0.2 μm. The particle size of the obtained liposome was measured by a laser scattering particle size distribution analyzer (NIC
The particle size was 180 nm (CV value 14%) when measured using OCOM, NICOMP370HPL (trademark). After leaving the liposomes at 5 ° C. for 3 weeks,
When the particle size was measured again, it was 192 nm (CV value 18%).
It was excellent in stability.
Claims (1)
グリセロール誘導体。 【化1】 (式(2)において、Mは1価のカウンターイオン、式
(3)において、R3は水素原子またはメチル基を表わ
す。)を表わす。R1C(=O)およびR2C(=O)は炭素
数3〜30の脂肪酸のアシル残基を表わし、同一でも異
なっていてもよい。nは2〜6の正数を表わす。)1. A diacylglycerol derivative represented by the following general formula (1). Embedded image (In the formula (2), M represents a monovalent counter ion, and in the formula (3), R 3 represents a hydrogen atom or a methyl group). R 1 C (═O) and R 2 C (═O) represent an acyl residue of a fatty acid having 3 to 30 carbon atoms and may be the same or different. n represents a positive number of 2 to 6. )
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19538695A JPH0940632A (en) | 1995-07-31 | 1995-07-31 | Diacylglycerol derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19538695A JPH0940632A (en) | 1995-07-31 | 1995-07-31 | Diacylglycerol derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0940632A true JPH0940632A (en) | 1997-02-10 |
Family
ID=16340304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19538695A Pending JPH0940632A (en) | 1995-07-31 | 1995-07-31 | Diacylglycerol derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0940632A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6904614B2 (en) | 2002-04-19 | 2005-06-14 | Ya-Man Ltd. | Glove with electrodes |
| JP2008507509A (en) * | 2004-07-20 | 2008-03-13 | クエストインターナショナル サービシーズ ビー.ブイ. | Flavor improving substance |
-
1995
- 1995-07-31 JP JP19538695A patent/JPH0940632A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6904614B2 (en) | 2002-04-19 | 2005-06-14 | Ya-Man Ltd. | Glove with electrodes |
| JP2008507509A (en) * | 2004-07-20 | 2008-03-13 | クエストインターナショナル サービシーズ ビー.ブイ. | Flavor improving substance |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0373038B1 (en) | New lysosphingolipid derivatives | |
| CA1333719C (en) | .alpha.-aminodicarboxylic acid derivatives, their preparation and their use | |
| JPH0940632A (en) | Diacylglycerol derivative | |
| JP3697189B2 (en) | Phospholipid base exchange method | |
| CN115785147B (en) | A single-chain fatty acid choline phosphate lipid, its preparation method and application | |
| CN1200945C (en) | Process for acylation of amino alcohols | |
| JP2909279B2 (en) | Preparation of phosphatidylcholine derivatives | |
| JPH0455433B2 (en) | ||
| JP4412427B2 (en) | Process for producing mixed acid type 1,2-diacyl-3-glycerophospholipid | |
| JP3498339B2 (en) | Phospholipid derivatives | |
| US4690784A (en) | Process for preparing phosphatidylcholine derivatives | |
| JPH0572915B2 (en) | ||
| JP2884105B2 (en) | Method for producing phosphatidylcholine | |
| JP2887617B2 (en) | Method for producing phosphatidylcholine | |
| JPH0327556B2 (en) | ||
| JPS61275287A (en) | Production of synthetic phosphatidylcholine | |
| JP3498336B2 (en) | Phospholipid derivatives | |
| CN106562929A (en) | Method for preparing novel lipidosome-coated spinning targeted nanoparticle L-MPBN medicinal compound | |
| JPS61275286A (en) | Production of phosphatidylcholine | |
| JPS5940839B2 (en) | Method for producing mixed acid type 1,2-diacyl-3-glycerylphosphorylcholines | |
| JPH0931041A (en) | 1,2-diacylglycerol derivative | |
| JP4449147B2 (en) | Method for producing phosphatidylethanolamine derivative | |
| JP2546289B2 (en) | Method for producing synthetic lecithin | |
| JP2002275187A (en) | Method for producing phosphatidylcholine | |
| KR100243554B1 (en) | Process for producing lysophospholipid from the derivatives of glycerophosphatidic acid |